AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Viatris CCO Corinne Le Goff Sells 7032 Shares for $71,590 on Sept 11
ByAinvest
Friday, Sep 12, 2025 6:07 pm ET1min read
Viatris Inc. has announced that Chief Commercial Officer Corinne Le Goff has recently sold 7,032 shares at a price of $10.25 per share on September 11, 2025.
Theravance Biopharma (TBPH) has seen a significant increase in its stock price following its most recent earnings report. Shares have added about 9.8% in the past month, outperforming the S&P 500 [1]. The company reported a narrower-than-expected adjusted net loss of 8 cents per share for the second quarter of 2025, compared to the Zacks Consensus Estimate of a 14-cent loss. This was an improvement over the year-ago quarter, where the company incurred an adjusted loss of 13 cents per share [1].Revenues for the second quarter totaled $26.2 million, which was a 83.2% increase year-over-year. This was driven by increased collaboration revenues from partner Viatris and licensing revenues. Specifically, revenues from the Viatris collaboration reached $18.7 million, up 31% year-over-year, and the company received a milestone payment of $7.5 million from Viatris following the approval of Yupelri in China [1].
Research and development expenses (excluding share-based compensation) totaled $9.5 million, an increase of almost 8% from the year-ago quarter. Selling, general, and administrative expenses (excluding share-based compensation) also increased by around 16.4% year-over-year to $12.8 million [1].
As of June 30, 2025, Theravance had $338.8 million in cash, cash equivalents, and marketable securities compared to $130.9 million as of March 31, 2025 [1].
The company reaffirmed its financial guidance for 2025, expecting adjusted R&D expenses to be in the range of $32-$38 million, adjusted SG&A expenses to be between $50 million and $60 million, and share-based compensation expenses to be $18-$20 million. The company expects adjusted losses and cash burn in 2025 to be similar to 2024 levels [1].
Investors have been optimistic about the stock, with estimates trending upward and a VGM Score of A [1]. However, the stock has a Zacks Rank of #3 (Hold), suggesting an in-line return in the next few months [1].
In other news, Viatris Inc. has announced that Chief Commercial Officer Corinne Le Goff sold 7,032 shares at a price of $10.25 per share on September 11, 2025 [2]. This insider trading activity may indicate a shift in the company's outlook or a change in the executive's personal financial strategy.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet